Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 3.32
IRTC's Cash-to-Debt is ranked higher than
59% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. IRTC: 3.32 )
Ranked among companies with meaningful Cash-to-Debt only.
IRTC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.18  Med: 1.38 Max: 3.32
Current: 3.32
0.18
3.32
Equity-to-Asset 0.65
IRTC's Equity-to-Asset is ranked higher than
57% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. IRTC: 0.65 )
Ranked among companies with meaningful Equity-to-Asset only.
IRTC' s Equity-to-Asset Range Over the Past 10 Years
Min: -4.35  Med: -0.37 Max: 0.67
Current: 0.65
-4.35
0.67
Debt-to-Equity 0.38
IRTC's Debt-to-Equity is ranked lower than
54% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.35 vs. IRTC: 0.38 )
Ranked among companies with meaningful Debt-to-Equity only.
IRTC' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.96  Med: -0.08 Max: 0.38
Current: 0.38
-2.96
0.38
Debt-to-EBITDA -1.85
IRTC's Debt-to-EBITDA is ranked lower than
99.99% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. IRTC: -1.85 )
Ranked among companies with meaningful Debt-to-EBITDA only.
IRTC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.89  Med: -1.44 Max: -0.42
Current: -1.85
-1.89
-0.42
Piotroski F-Score: 6
Altman Z-Score: 14.85
Beneish M-Score: -2.52
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % -21.89
IRTC's Operating Margin % is ranked lower than
76% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.72 vs. IRTC: -21.89 )
Ranked among companies with meaningful Operating Margin % only.
IRTC' s Operating Margin % Range Over the Past 10 Years
Min: -67.89  Med: -59.85 Max: -21.89
Current: -21.89
-67.89
-21.89
Net Margin % -27.35
IRTC's Net Margin % is ranked lower than
76% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. IRTC: -27.35 )
Ranked among companies with meaningful Net Margin % only.
IRTC' s Net Margin % Range Over the Past 10 Years
Min: -72.79  Med: -63.09 Max: -27.35
Current: -27.35
-72.79
-27.35
ROE % -76.82
IRTC's ROE % is ranked lower than
90% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.68 vs. IRTC: -76.82 )
Ranked among companies with meaningful ROE % only.
IRTC' s ROE % Range Over the Past 10 Years
Min: -76.82  Med: 0 Max: 0
Current: -76.82
-76.82
0
ROA % -23.92
IRTC's ROA % is ranked lower than
79% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.36 vs. IRTC: -23.92 )
Ranked among companies with meaningful ROA % only.
IRTC' s ROA % Range Over the Past 10 Years
Min: -85.54  Med: -80.87 Max: -23.75
Current: -23.92
-85.54
-23.75
ROC (Joel Greenblatt) % -293.92
IRTC's ROC (Joel Greenblatt) % is ranked lower than
89% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.63 vs. IRTC: -293.92 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
IRTC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -898.16  Med: -536.83 Max: -293.92
Current: -293.92
-898.16
-293.92
GuruFocus has detected 3 Warning Signs with iRhythm Technologies Inc IRTC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» IRTC's 30-Y Financials

Financials (Next Earnings Date: 2017-12-05 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

IRTC Guru Trades in

Q4 2016

IRTC Guru Trades in Q4 2016

Steven Cohen 318,973 sh (New)
Columbia Wanger 553,847 sh (New)
» More
Q1 2017

IRTC Guru Trades in Q1 2017

Jim Simons 87,200 sh (New)
Columbia Wanger 589,147 sh (+6.37%)
Steven Cohen Sold Out
» More
Q2 2017

IRTC Guru Trades in Q2 2017

Steven Cohen 602,000 sh (New)
Jim Simons 274,800 sh (+215.14%)
Columbia Wanger 1,159,267 sh (+96.77%)
» More
» Details

Insider Trades

Latest Guru Trades with IRTC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NYSE:GKOS, TSE:3593, NAS:ATRI, SZSE:300171, ROCO:1565, SZSE:300358, XKLS:7153, NAS:OSUR, SZSE:300061, SZSE:300595, NAS:LMNX, XMCE:FAE, LSE:AMS, XKRX:048260, SHSE:603222, NAS:ATRC, TSE:7730, SHSE:600288, NAS:LMAT, SHSE:603987 » details
Traded in other countries:I25.Germany,
Headquarter Location:USA
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.

Top Ranked Articles about iRhythm Technologies Inc

iRhythm Technologies to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
iRhythm Technologies to Report Second Quarter 2017 Financial Results on August 2, 2017
iRhythm Technologies Names UC Berkeley Faculty Member Bruce G. Bodaken and Duke University Chancellor Emeritus Ralph Snyderman, M.D. to its Board of Directors
Research Collaboration Demonstrates Use of Deep Learning to Develop Expert Level Comprehensive Cardiac Arrhythmia Detection Algorithm
New Expert Statement Recognizes Patch Monitors Such as Zio by iRhythm as Effective for Atrial Fibrillation Monitoring Post-Ablation
Insiders Roundup: Medley Capital, LHC Group Largest insider buys and sales of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and All Insider Sales to “$5,000,000+.” Read more...
iRhythm Technologies Announces First Quarter 2017 Financial Results
iRhythm Technologies to Report First Quarter 2017 Financial Results on May 3, 2017
Zio by iRhythm Gains Further Recognition as Key Diagnostic Cardiac Monitoring System by US and UK Health Organizations

Ratios

vs
industry
vs
history
PB Ratio 13.07
IRTC's PB Ratio is ranked lower than
93% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. IRTC: 13.07 )
Ranked among companies with meaningful PB Ratio only.
IRTC' s PB Ratio Range Over the Past 10 Years
Min: 6.39  Med: 9.2 Max: 13.31
Current: 13.07
6.39
13.31
PS Ratio 13.88
IRTC's PS Ratio is ranked lower than
91% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.36 vs. IRTC: 13.88 )
Ranked among companies with meaningful PS Ratio only.
IRTC' s PS Ratio Range Over the Past 10 Years
Min: 7.99  Med: 10.68 Max: 14.11
Current: 13.88
7.99
14.11
EV-to-EBIT -58.31
IRTC's EV-to-EBIT is ranked lower than
99.99% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.17 vs. IRTC: -58.31 )
Ranked among companies with meaningful EV-to-EBIT only.
IRTC' s EV-to-EBIT Range Over the Past 10 Years
Min: -59.35  Med: -43.25 Max: -29.4
Current: -58.31
-59.35
-29.4
EV-to-EBITDA -61.06
IRTC's EV-to-EBITDA is ranked lower than
99.99% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.83 vs. IRTC: -61.06 )
Ranked among companies with meaningful EV-to-EBITDA only.
IRTC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -62.15  Med: -45.1 Max: -30.5
Current: -61.06
-62.15
-30.5
EV-to-Revenue 13.53
IRTC's EV-to-Revenue is ranked lower than
88% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. IRTC: 13.53 )
Ranked among companies with meaningful EV-to-Revenue only.
IRTC' s EV-to-Revenue Range Over the Past 10 Years
Min: 8.1  Med: 10.25 Max: 13.5
Current: 13.53
8.1
13.5
Current Ratio 8.15
IRTC's Current Ratio is ranked higher than
90% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. IRTC: 8.15 )
Ranked among companies with meaningful Current Ratio only.
IRTC' s Current Ratio Range Over the Past 10 Years
Min: 1.91  Med: 3.74 Max: 9.98
Current: 8.15
1.91
9.98
Quick Ratio 8.07
IRTC's Quick Ratio is ranked higher than
92% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. IRTC: 8.07 )
Ranked among companies with meaningful Quick Ratio only.
IRTC' s Quick Ratio Range Over the Past 10 Years
Min: 1.73  Med: 3.61 Max: 9.88
Current: 8.07
1.73
9.88
Days Inventory 20.87
IRTC's Days Inventory is ranked higher than
95% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.23 vs. IRTC: 20.87 )
Ranked among companies with meaningful Days Inventory only.
IRTC' s Days Inventory Range Over the Past 10 Years
Min: 20.87  Med: 24.37 Max: 28.19
Current: 20.87
20.87
28.19
Days Sales Outstanding 49.03
IRTC's Days Sales Outstanding is ranked higher than
72% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.37 vs. IRTC: 49.03 )
Ranked among companies with meaningful Days Sales Outstanding only.
IRTC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.03  Med: 56.33 Max: 98.23
Current: 49.03
49.03
98.23
Days Payable 40.17
IRTC's Days Payable is ranked lower than
61% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.31 vs. IRTC: 40.17 )
Ranked among companies with meaningful Days Payable only.
IRTC' s Days Payable Range Over the Past 10 Years
Min: 36.23  Med: 36.76 Max: 41.25
Current: 40.17
36.23
41.25

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 18.20
IRTC's Price-to-Net-Cash is ranked lower than
56% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.35 vs. IRTC: 18.20 )
Ranked among companies with meaningful Price-to-Net-Cash only.
IRTC' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 10.99  Med: 15.01 Max: 18.5
Current: 18.2
10.99
18.5
Price-to-Net-Current-Asset-Value 14.88
IRTC's Price-to-Net-Current-Asset-Value is ranked lower than
74% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.73 vs. IRTC: 14.88 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
IRTC' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 9.09  Med: 12.28 Max: 15.13
Current: 14.88
9.09
15.13
Price-to-Tangible-Book 13.21
IRTC's Price-to-Tangible-Book is ranked lower than
84% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.82 vs. IRTC: 13.21 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
IRTC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7.24  Med: 9.42 Max: 13.43
Current: 13.21
7.24
13.43
Price-to-Median-PS-Value 1.30
IRTC's Price-to-Median-PS-Value is ranked lower than
64% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. IRTC: 1.30 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
IRTC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.84  Med: 1.03 Max: 1.33
Current: 1.3
0.84
1.33
Earnings Yield (Greenblatt) % -1.72
IRTC's Earnings Yield (Greenblatt) % is ranked lower than
68% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. IRTC: -1.72 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
IRTC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3.4  Med: -2.3 Max: -1.69
Current: -1.72
-3.4
-1.69

More Statistics

Revenue (TTM) (Mil) $80.78
EPS (TTM) $ -0.81
Short Percentage of Float10.73%
52-Week Range $22.16 - 53.10
Shares Outstanding (Mil)22.73

Analyst Estimate

Dec17 Dec18 Dec19 Dec20
Revenue (Mil $) 96 129 176 223
EPS ($) -1.10 -0.68 -0.03 0.52
EPS without NRI ($) -1.10 -0.68 -0.03 0.52
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAN
Positive CFROAN
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}